The details of FoldDB ID: fd0334 |
|---|
Use the buttons at the bottom of Jsmol viewer to see different representations, ON/OFF Hydrogens, and ON/OFF rotation.
3D model is for representation purpose only. To access the experimental 3D structure kindly go to the browse structure tab and look for PDB or CCDC id.
.
.
| Identification | |
|---|---|
| FoldDB ID | fd0334 |
| One Letter code
Since there is no uniform representation for the non-natural peptides. The one letter code reported here is as it is mentioned in the original article and/or the external database. | RRRRRRRRRPKβ3IIQβ3SVGIβ3SNLKβ3NL |
| Three Letter code
Since there is no uniform representation for the non-natural peptides. The three letter code reported here is as it is mentioned in the original article and/or the external database. | Ac-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Lys-β3Ile-Ile-Gln-β3Ser-Val-Gly-Ile-β3Ser-Nle-Lys-β3Nle-NH2 |
| Source | synthetic construct |
| External ID | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Reaxys ID | 32389742 | ||||||||
| Structural Information | |
|---|---|
| Structure reported | no |
| Other information | |
|---|---|
| Application | Anti-leishmanial activity |
| Foldamer type | α/β Peptide |
| Activity |
|---|
| Activity ID | Assay name | Cell line | Target Protein | Organism | Assay Category | Value | Unit | Type | Measurement object |
|---|---|---|---|---|---|---|---|---|---|
| fdact1018 | Leishmania infantum | In Vitro (Efficacy) | 0.98 | µM | LC50 | ||||
| fdact1019 | Leishmania infantum | In Vitro (Efficacy) | 1.9 | µM | LC50 | ||||
| fdact1020 | THP-1 cell line | Toxicity/Safety Pharmacology | 5.8 | µM | LC50 |
| Citations | |||||
|---|---|---|---|---|---|
| ID | Title | Year | Authors | Journal | DOI |
Improved proteolytic stability and potent activity against Leishmania infantum trypanothione reductase of α/β-peptide foldamers conjugated to cell-penetrating peptides | 2017 | de Lucio H., Gamo A.M., Ruiz-Santaquiteria M., de Castro S., Sánchez-Murcia P.A., Toro M.A., Gutiérrez K.J., Gago F., Jiménez-Ruiz A., Camarasa M.-J., Velázquez S. | European Journal of Medicinal Chemistry | ||
